Question 1

How many shares of LGND does CULLEN/FROST BANKERS, INC. own?

Accepted Answer

CULLEN/FROST BANKERS, INC. previously held 0 shares of LGND (LIGAND PHARMACEUTICALS) before exiting the position in 2021-Q2.

Question 2

What is CULLEN/FROST BANKERS, INC.'s LGND position worth?

Accepted Answer

CULLEN/FROST BANKERS, INC.'s LGND position was last reported at $0 in 2021-Q2 before the exit.

Question 3

Is CULLEN/FROST BANKERS, INC. buying or selling LGND?

Accepted Answer

In 2021-Q2, CULLEN/FROST BANKERS, INC. exited their LGND position entirely (-100.0% change in shares).

Question 4

When did CULLEN/FROST BANKERS, INC. first buy LGND?

Accepted Answer

Based on available 13F filings, CULLEN/FROST BANKERS, INC. first reported a position in LGND in 2019-Q1. They have held the position across 10 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$84.25	0
2021-Q1	Unchanged	10	0.0%	$2,000	0.0%	$93.02	0
2020-Q4	Unchanged	10	0.0%	$1,000	0.0%	$64.02	0
2020-Q3	Unchanged	10	0.0%	$1,000	0.0%	$59.76	0
2020-Q2	Unchanged	10	0.0%	$1,000	0.0%	$70.51	0
2020-Q1	Unchanged	10	0.0%	$1,000	0.0%	$44.42	0
2019-Q4	Unchanged	10	0.0%	$1,000	0.0%	$64.87	0
2019-Q3	Unchanged	10	0.0%	$1,000	0.0%	$61.73	0
2019-Q2	Unchanged	10	0.0%	$1,000	0.0%	$71.21	0
2019-Q1	New	10	-	$1,000	0.0%	$78.42	17

LGND10 quarters

LGND
10 quarters